You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API ciclopirox


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ciclopirox

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
E Fougera & Co a division of Fougera Pharmaceuticals Inc CICLOPIROX ciclopirox 0168-0522 DISODIUM LAURETH SULFOSUCCINATE
E Fougera & Co a division of Fougera Pharmaceuticals Inc CICLOPIROX ciclopirox 0168-0522 LAURETH-2
E Fougera & Co a division of Fougera Pharmaceuticals Inc CICLOPIROX ciclopirox 0168-0522 SODIUM CHLORIDE
E Fougera & Co a division of Fougera Pharmaceuticals Inc CICLOPIROX ciclopirox 0168-0522 SODIUM LAURETH-3 SULFATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing ciclopirox

Company Ingredient NDC Excipient
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0314 BENZYL ALCOHOL
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0314 CETYL ALCOHOL
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0314 COCO DIETHANOLAMIDE
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0314 LACTIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for ciclopirox

Excipient focus: ((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE

ciclopirox drug variants not containing ((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0314
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0407
Fougera Pharmaceuticals Inc ciclopirox 0168-0449
E Fougera & Co a division of Fougera Pharmaceuticals Inc ciclopirox 0168-0522
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTYL ESTER OF METHYL VINYL ETHER-MALEIC ANHYDRIDE COPOLYMER

Excipient focus: BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CETYL ALCOHOL

Excipient focus: COCAMIDE

Excipient focus: COCO DIETHANOLAMIDE

Excipient focus: DISODIUM LAURETH SULFOSUCCINATE

Excipient focus: DOCUSATE SODIUM

Excipient focus: ETHYL ACETATE

Excipient focus: ISOPROPYL ACETATE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTIC ACID

Excipient focus: LAURETH-2

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MALEIC ACID

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: MINERAL OIL

Excipient focus: MYRISTYL ALCOHOL

Excipient focus: OCTYLDODECANOL

Excipient focus: PEG/PPG-18/18 DIMETHICONE

Excipient focus: POLYSORBATE 60

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURETH SULFATE

Excipient focus: SODIUM LAURETH-2 SULFATE

Excipient focus: SODIUM LAURETH-3 SULFATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: STEARYL ALCOHOL

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group